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SUMMARY – In 1937, Ugo Cerletti and Lucio Bini performed electroconvulsive treatment 
(ECT) in Rome for the first time. That was the time when different types of ‘shock therapy’ were 
performed; beside ECT, insulin therapies, cardiazol shock therapy, etc. were also performed. In 1938, 
Cerletti and Bini reported the results of ECT. Since then, this method has spread rapidly to a large 
number of countries. As early as 1940, just two years after the results of the ECT had been published, 
it was also introduced in Croatia, at Sestre milosrdnice Hospital, for the first time in our hospital and 
in the then state of Yugoslavia. Since 1960, again the first in Croatia and the state, we performed ECT 
in general anesthesia and continued it down to the present, with a single time brake.
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General History of Electroconvulsive Therapy
Electroconvulsive therapy (ECT) is one of the old-
est methods of treatment in psychiatry, which was first 
introduced into clinical practice in Rome in 1937. 
 Another name for such therapy was ‘shock therapy’; 
insulin therapy and chemical convulsive therapy were 
also classified into this category. The concept of ‘shock 
therapy’ originated in France in the 1920s, and in 1926, 
the French psychiatrist Constance Pascal introduced 
this term into psychiatric practice1. ECT was also in-
cluded in one of the four somatic therapies for the 
treatment of psychiatric diseases, which have been 
used since the 1930s. The first such therapy was the 
aforementioned insulin therapy, which was introduced 
in clinical practice in 1933 by the Austrian psychiatrist 
Manfred Sakel. Based on his observations, he conclud-
ed that increased adrenaline levels were responsible for 
many mental health problems and began using insulin 
as an adrenaline antagonist. Then, in 1934, chemical 
convulsive therapy was introduced, initially with cam-
phor and then with cardiazol (Metrazol). Egas Moniz 
began to practice prefrontal lobotomy 1935. In 1938, 
Ugo Cerletti and Lucio Bini in Italy started using 
ECT, which is the only one of the four somatic thera-
pies used until today2. As noted above, discovery of 
ECT was preceded by discovery of chemical convul-
sive therapy. In the late 1920s, a Hungarian psychia-
trist and researcher Ladislas Meduna was involved in 
the investigation of epilepsy histopathology, where he 
found on two occasions that the condition of patients 
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with schizophrenia had improved after an epileptic 
seizure. Based on that observation, he concluded that 
there was a certain biological antagonism between 
these diseases. The results of a scientific study in which 
eight of 6000 patients with schizophrenia suffered 
from epilepsy contributed to this theory. This led to the 
idea of inducing epileptic attack with a chemical agent, 
which was yet to be discovered. Meduna identified 
camphor as an active substance that met the required 
criteria and on January 2, 1934, he applied camphor by 
intramuscular injection in a human for the first time3. 
In his autobiography, Meduna described a patient who 
had been in catatonic stupor for four years, lay in bed 
like a wooden figure, did not move, refused food and 
had to be fed through a nasogastric tube. After admin-
istering 5 injections of camphor, for the first time in 
four years, the patient got out of bed on his own, start-
ed talking, even asked for breakfast himself, and be-
came interested in his surroundings. Meduna believed 
that predisposition for epilepsy was a simple indicator 
of the patient’s ability to self-recover4. Over the next 
two years, he applied ECT in more than 100 patients, 
at least half of which recovered. Over time, camphor 
was replaced with another agent, cardiazol (Metrazol), 
which he found to be able to cause epileptic attacks at 
high enough doses. Soon, such treatment became 
known as convulsive therapy3. A few years later, in 
1937, a conference on pharmacological convulsive 
therapy was held in Switzerland, organized by psychi-
atrist Max Müller. The Proceedings on Convulsive 
Therapy was published in the American Journal of 
Psychiatry and, over the next three years, convulsive 
therapy began to be applied worldwide. However, cer-
tain serious complications of such treatment have been 
reported, such as unpleasant sensations and intense 
fear preceding loss of consciousness, general restless-
ness, vein thrombosis, and vertebral fractures following 
severe epileptic seizures induced with cardiazol. Such 
treatment was dangerous and costly and the perfor-
mance was complicated for medical staff, which led to 
the search for alternative ways of causing seizures. One 
way was to use electricity to induce seizures. The initia-
tors of this form of therapy were Italian Professor Ugo 
Cerletti and his colleague Lucio Bini, who began using 
electric shocks to cause epileptic attack in animals. The 
idea of  using electroshock (ES) in humans developed 
when Cerletti saw the use of ES for anesthesia in pigs 
before slaughter. At meetings in Münsingen in 1937, 
Lucio Bini described the process of inducing an epi 
attack by electrical stimulus in dogs using a self-de-
signed apparatus. What both Meduna and Cerletti 
observed was that the cause of the epileptogenic stim-
ulus was not important but rather the most important 
thing was the epileptic seizure, regardless of how it was 
induced. The method consisted of the initial applica-
tion of a weak calibration current that passed through 
two electrodes positioned on the patient’s head with a 
special support structure that measured head resis-
tance. Based on this value, an adequate voltage level 
would be chosen to trigger an epi attack. The first com-
pany to be licensed to produce Bini’s ES apparatus was 
Officine Elettrotecniche Italiane Ing. Vittorio Arcioni 
S.a.s. In October 1938, Lucio Bini applied for a patent 
that was protected in March 1939, officially becoming 
the inventor of ECT apparatus5. However, such attacks 
were accompanied by numerous and serious complica-
tions and his colleagues continued to search for the 
characteristics of electricity that would cause a less se-
vere attack that would be safer for patients. They con-
cluded that current of 125 V with a duration of one 
second on the bitemporal electrodes was safe. In April 
1938, ECT was first applied in humans. It was a pa-
tient who was found wandering the streets of Rome, 
spoke in neologisms, had thought-provoking phe-
nomena, with emotional detachment. He had been 
successfully treated previously with cardiazol on nu-
merous occasions. Following the first application, the 
patient spoke coherently, after which the ES was ap-
plied 10 more times3. Soon the ECT was applied not 
only in Italy but in other parts of the world as well. Dr. 
Renato Almassi, Professor Cerletti’s associate in 
Rome, brought the ECT apparatus to the USA. The 
first ES in America was administered by Dr. David 
Impastato at Columbus Hospital, New York, in Janu-
ary 19402. Apart from him, Lothar Kalinowsky, a Ger-
man psychiatrist who practiced psychiatry in Rome 
with Cerletti before emigrating to New York in 1940, 
is mentioned as one of the significant initiators of 
ECT in the USA1. At the same time, ECT began to be 
applied sporadically in the Scandinavian countries, 
most notably in Denmark and Sweden, where it en-
tered in regular use at university departments as early 
as the end of 1940. In the UK, they began to apply 
ECT in 1938, but after 1960 it was more stigmatized 
than in the US1. In order to modify the use of electric-
ity in 1942, Emerick Friedman and Paul H. Wilcox in 
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Massachusetts proposed setting up a unilateral elec-
trode to reduce cognitive impairment in patients. In 
addition, there were techniques where a shorter im-
pulse current was applied and was called short stimu-
lus therapy. Wladimir Liberson in Connecticut pro-
posed this type of therapy that used currents that were 
1/30 of Cerletti’s dose and thus shortened pulses, and 
invented a machine that could generate up to 250 such 
pulses per second. Later, Liberson increased the pulse 
amplitude with each cycle and with this mode, excel-
lent results were reported in depressed patients1. There 
has long been controversy over positioning of elec-
trodes, which method has fewer side effects and great-
er efficiency. It was later found that high doses in the 
right unilateral ECT acted as well as bilateral ECT6. 
The advantages of ECT over chemical convulsive 
therapy were the simplicity of the technique, safety of 
the reaction, faster and more efficient loss of con-
sciousness (thus eliminating the unpleasant feeling of 
fear) and the possibility of applying muscle relaxants7. 
However, the goal was to find a way of eliminating 
convulsions while maintaining therapeutic effect. In 
order to reduce the strong physical exertion of the pa-
tient during convulsion, various methods were used to 
achieve muscle relaxation. ECT with the use of barbi-
turates and myorelaxants is called mitigated ECT. The 
pioneer of the mitigated ES was E.E. Benett who used 
the curare muscle relaxant for the first time in 1940 to 
relieve convulsions. Ten years later, succinyl com-
pounds were introduced and are still in use today. The 
effect of succinyl was visible shortly after the applica-
tion when fasciculation of the affected musculature oc-
curred. Since succinyl compounds also cause respira-
tory musculoskeletal paralysis, which was an extremely 
uncomfortable feeling for a conscious patient, prior 
anesthesia was necessary. At that time, barbiturates, 
sub-convulsive doses of electrical current, and inhala-
tion anesthesia were used for the induction of anesthe-
sia. The mortality rate of native ES was very low, with 
some studies suggesting 0.05‰ to 0.2% of treated pa-
tients, but in the first phase of the introduction of 
mitigation, mortality increased due to a defective tech-
nique, extension of indications and significant defi-
ciencies of the induction agents that were in use at that 
time. However, the mitigated ES had numerous ben-
efits because it reduced the patient’s fear and the likeli-
hood of complications such as fractures, luxations, 
bites, myalgia, and also mortality was equal to that of 
general anesthesia8.
Electroconvulsive Therapy in Croatia
Electroconvulsive therapy has been used in Croatia 
since 1940, at the Sestre milosrdnice Hospital, now 
Sestre milosrdnice University Hospital Centre (UHC). 
The application of ECT at Sestre milosrdnice UHC 
began shortly after founding of the Department of 
Neurology and Psychiatry at Dr. M. Stojanović Gen-
eral Hospital in spring 1940. Although there “has been 
not a single case of fatal outcome as a direct or indirect 
complication of unmodified ECT since the founding 
of this Department, a mitigated electroshock has been 
introduced.”8. According to this report and medical 
records available, it is evident that ECT has been prac-
ticed in our hospital for 80 years now, i.e. since the very 
foundation of the Department of Neurology and Psy-
chiatry. During World War II, an apparatus was pur-
chased for the Neuropsychiatric Department, which 
was then located in Kukovićeva Street (now, Faculty of 
Chemical Biotechnology is located in these premises), 
predecessor of the present Department of Psychiatry, 
Zagreb University Hospital Centre. It was also noted 
that during insulin shortage in today’s Vrapče Psychi-
atric Hospital during World War II, ECT began to be 
applied by borrowing the apparatus from the institu-
tions in Zagreb that had it9. Already in 1960, we intro-
duced ECT under general anesthesia or mitigated ES, 
as it was then called (Fig. 1). This procedure was intro-
duced for the first time in Croatia and in the former 
state. Boško Barac, then specialist in our neuropsychi-
atric school, wrote: “Hudolin, an ambitious and hard-
working doctor, had a lot of misunderstandings with 
his associates. He wanted to introduce newer methods 
of treatment. Convinced that ES was unsurpassed in 
some psychiatric disorders, he was right to introduce a 
‘mitigated’ ES under anesthesia with muscle relaxants 
due to possible dangerous complications. At that time, 
there was no ‘ethics committee’, so Prof. Danko Riess-
ner (1907-1973), a pioneer of Croatian neurosurgery 
and Head of Surgery in Vinogradska Hospital, ap-
pointed me, along with the chief of anesthesia Dr. 
Neda Butigan (1929-1993), to be the first in Croatia 
and Yugoslavia to introduce this method as a routine. 
Trained in the basics of anesthesia and resuscitation 
and having mastered the technique of intubation, for a 
long time I practiced ‘mitigated ES’ with Hudolin’s 
formal assistance”10.
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In our routine, mitigated ES was used in selected 
cases, most often in those that had a strict contraindi-
cation for unmodified ES. Included in the group of 
patients with absolute contraindication were those 
with osteoporosis, osteoarticular lesions and deformi-
ties, or patients with strong musculature who were at 
risk of developing complications and patients with 
more severe cardiovascular disease (cardiac valve dam-
age, high hypertension, more severe atherosclerotic le-
sions, fresh cerebrovascular incidents, increased intra-
cranial pressure, etc.). A medical team consisting of 
physicians educated in the basics of anesthesia and 
resuscitation, and a nurse who also had appropriate an-
esthesia training, participated in the implementation. 
Patients were comprehensively clinically assessed prior 
to ECT. During the course of therapy, vital parameters 
were monitored along with other data (blood pressure, 
pulse, onset and end of apnea, etc.). An example of an-
esthesia chart used back then can be seen in Figure 2. 
The amount and time of administration of all medical 
agents was also recorded on special lists. The patients 
were on an empty stomach, with an empty bladder. 
Premedication was performed with 0.5 mg of atropine, 
most commonly before barbiturate administration. In 
this way, salivation and cough stimulation were pre-
vented and the whole procedure was safer for the pa-
tient. After atropine, 10% barbiturate (Kemithal) was 
injected with clinical titration at doses of 300 to 1000 
mg. Then, a Leptosuccin (45-90 mg) muscle relaxant 
was administered to the same needle to achieve safer 
relaxation. After half a minute, facial fasciculations 
would usually occur and then pure oxygen would be 
applied via the mask with CO2 absorption using the 
Sutjeska 1958 inhalation anesthesia device. After a 
dozen passive breaths, electricity was applied using the 
Siemens Convulsor 622 and a generalized type con-
vulsion would occur (Fig. 1). The patient was then 
briefly ventilated with oxygen but without CO2 ab-
sorption to accelerate spontaneous breathing. This 
whole process took 12 minutes per application. In this 
way, from February 1960 to February 1961, a total of 
30 patients were treated with a total of 120 applica-
tions. Temperature charts from the 1960s are shown in 
Fig. 1. Photograph from the 1960s 
when electroconvulsive therapy was 
performed under general anesthesia 
at Department of Psychiatry, Sestre 
milosrdnice University Hospital 
Centre. In the foreground is the 
Siemens Convulsator 622, used at 
the Department since the 1950s, 
while an older Siemens model was 
used before.
Fig. 2. Anesthesia chart from the 1960s.
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Figures 3 and 4, reflecting the concomitant use of psy-
chopharmacotherapy and ECT, along with the mea-
surement of vital parameters. The risk of cardiovascular 
complications was the cause of mitigation in 50% of 
cases, the risk of osteomuscular incidents in 20% of 
cases, and fear of native ES in others8. From the statis-
tics of the neuropsychiatric ward, a total of 139 pa-
tients were treated from 1964 to 1968. Of the total 
number of patients, there were 111 men and 28 wom-
en. Their age ranged from 17 to 62 years, with the 
highest number of patients in the 20-30 age group. 
There were 127 patients with schizophrenia, most of-
ten with a clinical picture of paranoid hallucinatory 
psychosis, or catatonia. After 2 to 3 applications of ES, 
improvement in the patient’s mental status was report-
ed. During hospital stay, they would have received 5 to 
10, maximum 15 to 20 ES. Of the 139 patients treated, 
15 were administered mitigated ES. Complications in-
cluded surgical complications (mandibular luxation in 
14 patients and compressive Th4-5 fracture in one pa-
tient), prolonged apnea, dyspnea in two cases, and twi-
light state in one patient. At that time, there were sev-
eral ways of treatment with ES. The first way was to 
achieve a typical grand mal convulsion. Secondly, the 
electric current did not reach the convulsive threshold 
but caused the onset of short-term loss of conscious-
ness with spasms of the musculature, but without the 
appearance of tonic-clonic seizure, which was called 
ES balance. This method was recommended for the 
elderly, those in poor general condition and in the 
stage of fracture consolidation. In special cases, in 
acute schizophrenic conditions and in acute death 
catatonia, block treatment was used, consisting of 3-4 
consecutive applications of ES daily for several days7.
Antipsychiatry Movement and ECT
The beginning of the anti-psychiatric movement 
goes back to the 1950s with the emergence of a divi-
sion between biological and psychoanalytic psychia-
trists. Biological psychiatrists resented institutional-
ization of patients, administration of high doses of 
neuroleptics, convulsive therapy with psychosurgery, 
whereas analytically oriented psychiatrists resented the 
non-scientific bases of psychoanalysis, which was con-
sidered costly and ineffective. The term ‘antipsychiatry’ 
was created in 1967 and was introduced by David 
Cooper, a South African psychoanalyst, many years af-
ter the movement had really begun. Other psychia-
trists participated in the promotion of the antipsychia-
try movement, most notably Michael Foucault in 
France, Ronald David Laing in the UK, and Thomas 
Szasz in the US. Alleged psychiatric abuse of patients 
by ECT was also popularized in Kesey’s novel One 
Flew over the Cuckoo’s Nest from 1962 and later through 
the film adaptation of the said novel11. The antipsy-
chiatry movement and the influence of the media thus 
added to the already existing stigma associated with 
ECT. The development of psychopharmacology in the 
1960s also contributed to the antagonism, marginal-
ization and stigmatization of ECT, given that this 
treatment seemed even more barbaric compared to the 
administration of drugs1. Public and professional per-
Fig. 4. Temperature sheet from the 1960s showing 
concomitant use of pharmacotherapy and electroconvulsive 
therapy.
Fig. 3. Electroconvulsive therapy application chart  
from the 1960s.
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ceptions of ECT as an invasive brain-damaging meth-
od caused the greatest controversy. Such beliefs fueled 
primitive fears of ‘soul damage’ that represents each 
person’s uniqueness. Due to all of the above, ECT was 
neglected by educators and a large number of psychia-
trists who completed their education between 1960 
and 1980, resulting in their deficiency in knowledge of 
this field12. However, over time, a new problem came 
to light, which was therapy-resistant depression. Kurt 
Witton, a psychiatrist who studied in Bologna and 
later emigrated to the US, in 1962 noted a significant 
improvement in neuroleptic-resistant patients after 
ECT, which again put the focus on the application and 
effectiveness of ECT. The American Psychiatric As-
sociation (APA) contributed to the return of ECT to 
clinical practice, setting up a working group for scien-
tific evaluation of the effectiveness of ECT in 1975. 
The report of the Working Group in 1978 was posi-
tive, and it was found that ECT had an essential role 
in the treatment of major depressive disorder, resistant 
mania and therapy resistant schizophrenia. In addi-
tion, guidelines for informed consent to ECT were 
been agreed, which led to the less authoritative ap-
proach to patients. In 1981, the Royal College of Psy-
chiatrists in the UK published similar guidelines for 
the application of ECT. Due to the repeated public 
pressure to limit ECT, in 1985 the National Institute 
of Mental Health organized a consensus conference. A 
group of participants concluded that ECT was an ef-
fective treatment for a limited number of mental ill-
nesses and that its use was safe when applied according 
to guidelines. They also recommended better monitor-
ing of the ECT implementation, the creation of addi-
tional national standards and better education, which 
prompted the APA to set up a second working group 
in 1990, which produced a more comprehensive report 
detailing indications, risks, informed consent and 
technical procedures for the application of modern 
and modified ECT, thus declaring that ECT plays a 
crucial role in psychiatric treatment1,12. Over time, the 
guidelines have become part of the continuing medical 
education creating better collaboration between psy-
chiatrists and anesthesiologists, which has contributed 
to the creation of medical teams capable of treating 
patients with severe somatic conditions, for whom 
ECT has been a viable option. In addition to the US, 
attacks from the public and various organizations were 
also present in other countries around the world. In 
the UK and Ireland, reports were also published in 
1981 and 1982 concerning the use of ECT, and it was 
restricted to private institutions and university depart-
ments. In some parts of India and China, unmodified 
ECT is still applied as it was 80 years ago12. More than 
80 years have elapsed since the discovery and intro-
duction of ECT into psychiatric practice, during 
which the ECT has experienced several ups and 
downs, from stigmatization and marginalization to the 
recognition of the effectiveness and safety of the ther-
apy itself. Nowadays, ECT is recognized as a superior 
method in the treatment of therapy resistant depres-
sion, suicidality, catatonia or mania, despite the fact 
that the exact neurochemical profile of ECT has not 
yet been discovered.
Current Situation in Croatia
In Croatia, the use of ECT is now regulated by the 
Act on the Protection of Persons with Mental Disor-
ders13. The Act states that ECT may be applied to a 
person with mental disability if the person with men-
tal disability has provided a written consent, if all oth-
er treatments have previously been exhausted, if the 
use of ECT is reasonably expected to be of real and 
direct benefit for the health of that person, and with-
out adverse side effects, of which opinion is given by 
the department physician, and ultimately if the ethics 
committee of the psychiatric institution or the ethics 
committee of the health institution has given positive 
opinion on the ethical acceptability of the use of ECT13. 
In Croatia, ECT is being applied today at Sestre mi-
losrdnice University Hospital Centre (SMUHC) and 
Zagreb University Hospital Centre. At SMUHC De-
partment of Psychiatry, ECT is applied after undergo-
ing diagnostic procedures according to the protocol for 
ECT, which includes blood panel (complete blood 
count, basic metabolic panel, thyroid hormone level), 
electrocardiogram, chest x-ray, brain computed to-
mography, and examination by ophthalmologist and 
anesthesiologist, then signing the informed consent 
and approval granted by the SMUHC Ethics Com-
mittee. The ECT is administered bilaterally (in some 
cases unilaterally) under general anesthesia usually on 
6 to 12 (in rare cases more than 12) occasions using a 
Thymatron System IV apparatus. Before general anes-
thesia, atropine is administered to decrease salivary 
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and bronchial secretion, and in some cases during an-
esthesia to keep the heart beat normal. Induction and 
maintenance of anesthesia is achieved with the intra-
venous agent propofol combined with nondepolariz-
ing muscle relaxant succinylcholine14. After induction, 
standard routine monitoring is conducted. Patient is 
ventilated with 100% oxygen at a rate of 15-20 breaths/
min, beginning approximately 1 min before the induc-
tion and continued until resumption of spontaneous 
breathing. ECT is administered by a psychiatrist. Ultra 
short pulse stimuli are used to trigger epileptic seizure. 
The power required to reach the neuromodulatory 
threshold is titrated to the achievement of the tonic-
clonic seizure recorded on the electroencephalogram. 
During the seizure, electromyogram and electroen-
cephalogram are monitored. Vital signs, agents for an-
esthesia, stimulus parameters, and duration of the 
spike wave complex are also noted on special charts. 
Many of our patients notice improvement after 6 
treatments and if needed we recommend maintenance 
therapy once a month after discharge from the hospi-
tal. This is the process of ECT treatment used at our 
Department of Psychiatry with which we have good 
results and which has proved effective when used ac-
cording to the guidelines.
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Sažetak
OSAMDESET GODINA ELEKTROKONVULZIVNE TERAPIJE U HRVATSKOJ  
I U KLINIČKOM BOLNIČKOM CENTRU SESTRE MILOSRDNICE
D. Karlović, V.A. Badžim, M. Vučić, H. Krolo Videka, A. Horvat, V. Peitl, A. Silić, B. Vidrih,  
B. Aukst-Margetić, D. Crnković i I. Ivančić Ravlić
Ugo Cerletti i Lucio Bini prvi put su izveli elektrokonvulzivnu terapiju (EKT) 1937. godine u Rimu. To je bilo doba kada 
su se provodile različite vrste “šok terapija”; uz EKT bile su to još inzulinske terapije, kardiazolski šokovi itd. O rezultatima 
EKT Cerletti i Bini izvijestili su 1938. godine i od tada se ta metoda vrlo brzo proširila u velik broj zemalja. Već 1940., samo 
dvije godine nakon objave rezultata o EKT, uvodi se i u Hrvatskoj u Bolnici Sestara milosrdnica, prvi puta u nas i u ondašnjoj 
državi Kraljevini Jugoslaviji. Od 1960. godine, opet prvi u Hrvatskoj i ondašnjoj državi, u našoj bolnici radimo EKT u općoj 
anesteziji sve do današnjih dana samo s jednim prekidom.
Ključne riječi: Elektrokonvulzivna terapija; Opća anestezija; Povijest; Bolnica; Hrvatska
